
AstraZeneca’s Lokelma has been approved by the National Medical Products Administration in China. This is due to positive results based …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

